Directors

Stephen A. Roth, Ph.D. Chairman Co-founder and former CEO of Neose; former Professor and Chairman of the Biology Department at the University of Pennsylvania; editorial board member of The Quarterly Review of Biology and The Journal of Molecular Recognition C. Boyd Clarke President and Chief Executive Officer Neose Technologies, Inc. L. Patrick Gage, Ph.D. Former Senior Vice President, Science and Technology, at Wyeth and President of Wyeth Research; former president of Genetics Institute; director of the Philadelphia Orchestra Association William F. Hamilton, Ph.D. Landau Professor of Management and Technology and Director of the Jerome Fisher Program in Management and Technology at The Wharton School and the School of Engineering and Applied Science at the University of Pennsylvania; Director of Centocor, Inc., Hunt Manufacturing Co., and Marlton Technologies, Inc. Douglas J. MacMaster, Jr. Former Senior Vice President of Merck & Co., Inc., responsible for worldwide chemical and pharmaceutical manufacturing; serves on the boards of numerous biotechnology and pharmaceutical companies P. Sherrill Neff Founding partner of Quaker BioVentures, L.P., a venture capital firm; former President and Chief Operating Officer of Neose Technologies; Former Senior Vice President, Corporate Development at U.S. Healthcare, Inc., a managed healthcare company; Managing Director and Co-head of Financial Services Group, Alex. Brown & Sons, an investment banking firm; Director of Resource America, Inc, The Bancorp.Com, Inc., Pennsylvania Biotechnology Association, The Biotechnology Institute and The University City Science Center Mark H. Rachesky, M.D. Founder and President of MHR Fund Management LLC; acting Chief Investment Advisor of Icahn Holding Corporation; Director of Samsonite Corporation Lowell E. Sears Former Chief Financial Officer of Amgen Inc.; Chairman of the Board of Directors of CoCensys Inc. and Director of Techne Corp. Elizabeth Wyatt Former Vice President, Corporate Licensing at Merck & Co.; serves on the board of directors of Medimmune, Inc. and The Seabury Group LLC and certain of its affiliates, as well as the board of trustees of Randolph-Macon College

Top | Management | Directors | Scientific Advisory Board | GlycoAdvance Advisory Board

Scientific Advisory Board

Merton Bernfield, M.D. Chief of Newborn Medicine at the Children's Hospital in Boston, Chairs the Department of Newborn Medicine at the Brigham & Women's and Beth Israel Hospitals; serves as the Clement A. Smith Professor of Pediatrics and Professor of Cell Biology at Harvard Medical School Henrik Clausen, DDS, DSc. Associate Professor, School of Denistry, Faculty of Health Sciences, University of Copenhagen; expert in the field of gene cloning and host cell expression of mammalian glycosyltransferases James C. Paulson, Ph.D. Professor of Molecular Biology at Scripps Research Institute; world renowned glycobiologist and inventor on several key patents licensed to Neose that relate to core, enabling technologies for GlycoAdvance; principal investigator on a $34 million NIGMS glue grant to fund the Consortium for Functional Glycomics; former Vice President of Research and Chief Scientific Officer of Cytel Corporation prior to Neose's acquisition of Cytel's carbohydrate synthesis technology in 1999 John F. Robyt, Ph.D. Professor of Biochemistry, Director of the Laboratory of Carbohydrate Chemistry and Enzymology, Iowa State University; expert in the mechanisms by which enzymes synthesize and hydrolyze polysaccharides, and discoverer of numerous chemical and enzymatic modifications of carbohydrates to produce new products Harry Schachter, M.D., Ph.D., FRSC Expert of international repute in glycoconjugates; served as Professor and Chairman of the Department of Biochemistry at the University of Toronto and as Head of the Division of Biochemistry Research at Toronto's Hospital for Sick Children Barry D. Shur, Ph.D. Professor and Chairman, Department of Anatomy and Cell Biology, Emory University School of Medicine; serves on the editorial boards of Glycobiology and Developmental Biology Elaine Tuomanen, M.D. Head, Laboratory of Molecular Infectious Diseases, St. Jude Children's Hospital George Whitesides, Ph.D. Mallinckrodt Professor of Chemistry at Harvard University and former Chairman of the Department of Chemistry at Harvard

Top | Management | Directors | Scientific Advisory Board | GlycoAdvance Advisory Board

GlycoAdvance Advisory Board

Henrik Clausen, DDS, DSc. Associate Professor, School of Dentistry, Faculty of Health Sciences, University of Copenhagen; expert in the field of gene cloning and host cell expression of mammalian glycosyltransferases Rick Cummings, Ph.D. Professor in the Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center David James, Ph.D. Associate Professor of Bioengineering, Department of Chemical Engineering, University of Queensland  has made important discoveries relating minor structural changes in the carbohydrate chains of monoclonal antibodies to major changes in the ability of the antibodies to turn on immune effector functions Howard L. Levine, Ph.D. President of Bioprocess Technology Consultants, a company that provides technical and economic advice to enable glycoprotein manufacturing and downstream processing for many major biotechnology companies worldwide. Dr. Levine previously had biological process development and manufacturing positions at Repligen, Amgen and Genentech James C. Paulson, Ph.D. Professor of Molecular Biology at Scripps Research Institute; world renowned glycobiologist and inventor on several key patents licensed to Neose that relate to core, enabling technologies for GlycoAdvance; principal investigator on a $34 million NIGMS glue grant to fund the Consortium for Functional Glycomics; former Vice President of Research and Chief Scientific Officer of Cytel Corporation prior to Neose's acquisition of Cytel's carbohydrate synthesis technology in 1999 Harry Schachter, M.D., Ph.D., FRSC Expert of international repute in glycoconjugates; served as Professor and Chairman of the Department of Biochemistry at the University of Toronto and as Head of the Division of Biochemistry Research at Toronto's Hospital for Sick Children Pamela Stanley, Ph.D. Professor of Cell Biology at Albert Einstein College of Medicine and a world leader in cytogenetics and glycosylation mechanisms in CHO cells, the cells most commonly used for production of therapeutic glycoproteins in the biotechnology industry

Top | Management | Directors | Scientific Advisory Board | GlycoAdvance Advisory Board